Results · Apr-Jun 2026
TCM Q1 FY27 results
Sales grew 52% to ₹4.9 crore from ₹3.2 crore in Apr-Jun 2025.
Operating profit was −₹0.98 crore, an operating margin of −20.0% (up 41.1 points from a year ago).
The net loss narrowed to ₹1.6 crore from ₹2.4 crore.
Against Jan-Mar 2026: sales −1%, loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 4.9 | 3.2 | +52% |
| Operating profit (EBITDA) | -1.0 | -2.0 | n/m |
| Operating margin | −20.0% | −61.1% | +41.1 pts |
| Net profit | -1.6 | -2.4 | loss narrows |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.